` AFX (Carl Zeiss Meditec AG) vs DAX Index Comparison - Alpha Spread

AFX
vs
DAX Index

Over the past 12 months, AFX has underperformed DAX Index, delivering a return of -41% compared to the DAX Index's 23% growth.

Stocks Performance
AFX vs DAX Index

Loading
AFX
DAX Index
Add Stock

Performance Gap
AFX vs DAX Index

Loading
AFX
DAX Index
Difference

Performance By Year
AFX vs DAX Index

Loading
AFX
DAX Index
Add Stock

Competitors Performance
Carl Zeiss Meditec AG vs Peers

Carl Zeiss Meditec AG
Glance View

Economic Moat
None
Market Cap
5.1B EUR
Industry
Health Care

Carl Zeiss Meditec AG stands as a beacon in the realm of medical technology, carving a niche through its innovative solutions in ophthalmology and microsurgery. Rooted in the prestigious legacy of the Zeiss Group, this company seamlessly fuses cutting-edge technology with practical medical applications. Its headquarters in Jena, Germany, serve as the crucible for pioneering research and development endeavors, channeling expertise into products that enhance both diagnostic and surgical capabilities. The heart of its operations revolves around creating technological marvels such as optical coherence tomography (OCT) instruments and surgical microscopes, which bring precision and enhanced clarity to the medical field. Through a well-executed blend of R&D and strategic acquisitions, Carl Zeiss Meditec consistently remains at the forefront of medical innovation, ensuring it meets the ever-evolving needs of the healthcare sector. Financially, the company thrives by selling its sophisticated medical devices directly to healthcare professionals, hospitals, and clinics worldwide. Rather than merely creating instruments, Carl Zeiss Meditec's business model is deeply entwined with providing comprehensive workflow solutions and service support, ensuring that medical practitioners extract maximum utility from their investments. By offering not just products but also extensive after-sales service and maintenance, the company builds sustained relationships with its clients, fostering a cycle of trust and repeat business. In addition, its engagement in training and support services enhances user competencies, ensuring the seamless integration of its technology into everyday medical practice and underscoring its commitment to elevating healthcare standards globally. Through this multifaceted approach, Carl Zeiss Meditec solidifies its position as an indispensable ally in the medical community, both as a supplier of state-of-the-art equipment and as a provider of essential healthcare solutions.

AFX Intrinsic Value
79.12 EUR
Undervaluation 26%
Intrinsic Value
Price
Back to Top